Skip to main content

Charles River Laboratories Cost of products sold (excluding amortization of intangible assets) revenue

  • CRL · NYSE
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$337.97−0.83%Close 13 Nov 2026 · Market value $16.04B

Cost of products sold (excluding amortization of intangible assets) revenue at Charles River Laboratories came to $202.4M for the quarter to 26 Sep 2026, up 2.8% from a year earlier.

As Charles River Laboratories reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$175.5MDec 2023$194.7MMar 2024$183.2MJun 2024$177.3MSep 2024$190.6MDec 2024$186.2MMar 2025$191.3MJun 2025$196.8MSep 2025$190.9MDec 2025$197.7MMar 2026$195.8MJun 2026$202.4MSep 2026
Charles River Laboratories Cost of products sold (excluding amortization of intangible assets) revenue, every reported period
Period endingCost of products sold (excluding amortization of intangible assets) revenueChange on a yearFiled
26 Sep 2026$202.4Mup 2.8%4 Nov 2026
27 Jun 2026$195.8Mup 2.3%5 Aug 2026
28 Mar 2026$197.7Mup 6.1%7 May 2026
27 Dec 2025$190.9Mup 0.2%18 Feb 2026
27 Sep 2025$196.8Mup 11.0%5 Nov 2025
28 Jun 2025$191.3Mup 4.4%6 Aug 2025
29 Mar 2025$186.2Mdown 4.3%7 May 2025
28 Dec 2024$190.6Mup 8.6%19 Feb 2025
28 Sep 2024$177.3Mup 13.0%6 Nov 2024
29 Jun 2024$183.2Mdown 1.0%7 Aug 2024
30 Mar 2024$194.7Mup 13.2%9 May 2024
30 Dec 2023$175.5Mdown 11.9%14 Feb 2024
30 Sep 2023$156.9Mdown 11.0%8 Nov 2023
1 Jul 2023$185.0Mdown 2.8%9 Aug 2023
1 Apr 2023$172.0Mdown 11.1%11 May 2023
31 Dec 2022$199.1Mup 2.0%22 Feb 2023
24 Sep 2022$176.3Mdown 8.2%2 Nov 2022
25 Jun 2022$190.3Mdown 4.5%3 Aug 2022
26 Mar 2022$193.4Mdown 2.3%4 May 2022
25 Dec 2021$195.2Mup 13.0%16 Feb 2022
25 Sep 2021$192.1Mup 18.2%3 Nov 2021
26 Jun 2021$199.3Mup 50.9%4 Aug 2021
27 Mar 2021$198.0Mup 23.4%4 May 2021
26 Dec 2020$172.8Mup 21.9%17 Feb 2021
26 Sep 2020$162.5Mup 12.3%29 Oct 2020
27 Jun 2020$132.0Mdown 13.0%5 Aug 2020
28 Mar 2020$160.5Mup 4.5%7 May 2020
28 Dec 2019$141.8Mup 0.9%11 Feb 2020
28 Sep 2019$144.8Mup 1.8%6 Nov 2019
29 Jun 2019$151.7Mup 3.3%31 Jul 2019
30 Mar 2019$153.6Mup 3.4%7 May 2019
29 Dec 2018$140.5M—13 Feb 2019
29 Sep 2018$142.3Mup 3.4%7 Nov 2018
30 Jun 2018$146.8Mup 5.1%8 Aug 2018
31 Mar 2018$148.5M—10 May 2018
30 Sep 2017$137.5M—9 Nov 2017
1 Jul 2017$139.7M—9 Aug 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Charles River Laboratories: Organic revenue (change on a year) · Revenue · Remaining performance obligations · Cost of services provided (excluding amortization of intangible assets) revenue · DSA revenue · RMS revenue · Manufacturing revenue · United States revenue · Europe revenue · Canada revenue · Asia Pacific revenue · financial statements

Every KPI and segment of CRL, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.